Clinical Trials Directory

Trials / Completed

CompletedNCT04637893

The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Screening programs have been associated with a substantial reduction in colorectal cancer (CRC) mortality through endoscopic resection of preneoplastic lesions and detection of early-stage invasive cancers. In March 2020, the World Health Organization declared as a pandemic the outbreak of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2. Since then, the SARS-CoV-2 have never stopped spreading, causing an unprecedented situation with highly restrictive considerations to be adopted by the majority of countries worldwide. Health-care facilities have been making an enormous effort to assist patients affected by COVID-19, while adopting measures to maintain a safe environment for patients and healthcare professionals. As a result, the usual workflow in endoscopy departments changed dramatically, leading to an increase in cancelled procedures, probably increasing the future burden of Colorectal Cancer due to delays in diagnosis.

Conditions

Interventions

TypeNameDescription
OTHERColonoscopyPt. underwent colonoscopy

Timeline

Start date
2020-12-16
Primary completion
2021-03-31
Completion
2021-03-31
First posted
2020-11-20
Last updated
2022-06-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04637893. Inclusion in this directory is not an endorsement.